Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Micro-X.
RELATED STOCKHEAD STORIES
Experts
Scopo’s Health Powerplays: Show me the (grant) money
Experts
Scopo’s health powerplays: A healthy earnings season
Health & Biotech
For medtech company Micro-X, COVID-19 highlighted the importance of being prepared
Experts
Scopo’s powerplays: It just won’t go down!
Health & Biotech
Imagion tech brings down Tesla
News
ASX Small Cap Lunch Wrap: What does Australia’s nascent COVID-19 recovery mean for investors?
Health & Biotech
Micro-X’s Rover gets the green light from the FDA
News
10 at 10: These ASX stocks are towering high this morning
Health & Biotech
Dr Boreham’s Crucible: Hydrix who?
Experts
Scopo’s health powerplays: quick vaccine hits and cheap buys
Experts
Scopo’s health powerplays: The cash caboose keeps rolling on
Experts
Scopo’s health powerplays: Markets are getting back to normal
Tech
Hydrix tries to cut through complexity with promises of $$$
Health & Biotech
The elective surgery stocks getting a boost from the easing of COVID-19 restrictions
Director Trades
Directors Trades: When you have to sell to pay a tax bill, why not sell to a colleague at a premium?
Experts
ScoPo’s health powerplays: The transition to greatest
News
